Concepedia

Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis

Julie Safirstein, Jonathan J. Grant, Emily Clausen, Deepika Savant, Rebecca Dezube, Gina Hong

Journal of Cystic Fibrosis · 2020 · 37 citations · 7 references

DOIFull text

Open access

Concepts

References

7

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

Peter G. Middleton, Marcus Mall, Pavel Dřevı́nek et al. · New England Journal of Medicine · 2019 · 2.1K citations · Full text

, , +16

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.4K citations · Full text

, , +14

The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry

Emily A. Knapp, Aliza K. Fink, Christopher H. Goss et al. · Annals of the American Thoracic Society · 2016 · 477 citations

, , +13

Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells

Jonathan A. Cohn, Theresa V. Strong, Marina R. Picciotto et al. · Gastroenterology · 1993 · 359 citations · Full text

, , +14

Treatment and Prognosis of Symptomatic Gallbladder Disease in Patients with Cystic Fibrosis

Robert C. Stern, Fred C. Rothstein, Carl F. Doershuk · Journal of Pediatric Gastroenterology and Nutrition · 1986 · 63 citations

, , +14